© 2020 MJH Life Sciences and Contagion Live. All rights reserved.
© 2020 MJH Life Sciences™ and Contagion Live. All rights reserved.
October 27, 2020
While they decided to discontinue this trial in hospitalized COVID-19 patients, Lilly is continuing their other trials with the medication for COVID-19 treatment.
October 26, 2020
Invasive C glabrata found to be most prevalent strain of Candida in stool of patients with C difficile infection, and likely resistant to caspofungin.
A glimpse into FDA advisor perspective just weeks before EUAs are anticipated to be sent.
The company is planning to move forward after receiving a recommendation from the DSMB to start up the trial again.
A case study examines a treatment for a hospitalized case of the virus.
October 25, 2020
Why it may be more prudent for prescribing clinicians to assume viral, rather than bacterial, infection while awaiting test results in presenting pediatric cases.